Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer.

Barbara ZellingerUlrich BodenhoferImmanuela A EngländerCornelia KronbergerPeter StrasserBrane GrambozovGerd FastnerMarkus StanaRoland ReitsamerKarl SotlarFelix SedlmayerFranz Zehentmayr

Published in: Genes (2020)

This two-phase study demonstrates that hsa-miR-375/RASD1 signaling is able to predict local control in early breast cancer patients, which-to our knowledge-is the first clinical report on a miR combined with one of its downstream target proteins predicting LC in breast cancer.

Keyphrases

cell proliferation
long non coding rna
long noncoding rna
early breast cancer
randomized controlled trial
mass spectrometry
clinical trial
liquid chromatography